Page last updated: 2024-08-26

nimbolide and Granulocytic Leukemia, Chronic

nimbolide has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aggarwal, BB; Gupta, SC; Hema, PS; Nair, M; Park, B; Phromnoi, K; Reuter, S1

Other Studies

1 other study(ies) available for nimbolide and Granulocytic Leukemia, Chronic

ArticleYear
Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species- and ERK-dependent up-regulation of death receptors, p53, and Bax.
    The Journal of biological chemistry, 2011, Jan-14, Volume: 286, Issue:2

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Colonic Neoplasms; Extracellular Signal-Regulated MAP Kinases; HCT116 Cells; HT29 Cells; Humans; Kidney Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Limonins; Lung Neoplasms; Multiple Myeloma; Pancreatic Neoplasms; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand; Tumor Suppressor Protein p53

2011